{"nctId":"NCT03889925","briefTitle":"Effect of Different Injection Regimens of Autologous Conditioned Plasma for Knee Osteoarthritis","startDateStruct":{"date":"2019-03-15","type":"ACTUAL"},"conditions":["Knee Osteoarthritis"],"count":64,"armGroups":[{"label":"Autologous conditioned plasma group","type":"EXPERIMENTAL","interventionNames":["Biological: Autologous conditioned plasma"]},{"label":"Autologous conditioned plasma with hyaluronic acid group","type":"EXPERIMENTAL","interventionNames":["Drug: Hyaluronan"]}],"interventions":[{"name":"Hyaluronan","otherNames":["Hymovis","Monovisc","Orthovisc"]},{"name":"Autologous conditioned plasma","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients between the ages of 30 and 80\n* Documented radiographic evidence of OA in the tibiofemoral or patellofemoral compartment of the involved knee (Kellgren-Lawrence grades 1-4)\n* Patients must have a documented diagnosis of primary OA for at least 6 weeks.\n\nExclusion Criteria:\n\n* Patients who have had viscosupplementation in the involved knee in the past 6 months.\n* Any patient who has had a corticosteroid injection in any joint within 3-months prior to screening will be excluded.\n* Patients with gout or rheumatologic disease will be excluded. Patients who have had a previous negative experience with HA.\n* Any patient who will have difficulty obtaining internet access, does not have an active e-mail address, or is unable to comprehend study documents or give informed consent will be excluded.","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Western Ontario and McMaster University's Osteoarthritis Index (WOMAC)","description":"Patient reported outcome measure; The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. A sum of the scores for all three subscales gives a total score. Higher scores indicate worse pain, stiffness, and functional limitations.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.9","spread":"15.6"},{"groupId":"OG001","value":"22.4","spread":"15.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.1","spread":"20.1"},{"groupId":"OG001","value":"22.3","spread":"16.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","spread":"15.3"},{"groupId":"OG001","value":"22.5","spread":"16.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.9","spread":"18.7"},{"groupId":"OG001","value":"22.7","spread":"19.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":"15.1"},{"groupId":"OG001","value":"27.1","spread":"23.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.7","spread":"17.8"},{"groupId":"OG001","value":"29.2","spread":"23.3"}]}]}]},{"type":"PRIMARY","title":"International Knee Documentation Committee Subjective Knee Evaluation Form","description":"Patient reported outcome measure; Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.1","spread":"17.3"},{"groupId":"OG001","value":"53.7","spread":"14.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.4","spread":"17.6"},{"groupId":"OG001","value":"56.9","spread":"17.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.1","spread":"16"},{"groupId":"OG001","value":"53.1","spread":"19.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.6","spread":"19.1"},{"groupId":"OG001","value":"55.7","spread":"21.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":"23.6"},{"groupId":"OG001","value":"53.4","spread":"24.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.9","spread":"20.1"},{"groupId":"OG001","value":"51.8","spread":"21.9"}]}]}]},{"type":"PRIMARY","title":"Knee Injury and Osteoarthritis Outcome Score","description":"Patient reported outcome measure; A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.4","spread":"13.5"},{"groupId":"OG001","value":"62.7","spread":"12.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":"18.8"},{"groupId":"OG001","value":"62.9","spread":"20.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.2","spread":"16.3"},{"groupId":"OG001","value":"62.5","spread":"18.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.8","spread":"17.7"},{"groupId":"OG001","value":"61.8","spread":"20.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.3","spread":"18.2"},{"groupId":"OG001","value":"59.8","spread":"19.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59.8","spread":"19.5"},{"groupId":"OG001","value":"59","spread":"24.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":[]}}}